Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

A number of discredited and outlandish claims made to FBI officials were released on Friday as part of the vast tranche of files that the US Department of Justice (DOJ) has published about Jeffrey ...